| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in AIM over the last quarter tilts toward buying: insiders added a net 125,825 shares worth roughly $24K. In the past 30 days, 1 insider bought and 0 sold. Purchases have clustered in the most recent filings.
Equels Thomas K (CEO &President) stands out among recent buyers, now holding an estimated $30K in AIM. A senior officer buying with their own money is generally read as a stronger signal than routine insider selling.
Classified under Biotechnology (Health Care sector), AIM's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 189.7K | $30.4K | +62.9K | |
| Dir | 28.4K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 25, 2021 | Appelrouth Stewart | Director | Buy | 10,638 | $2.35 | $24,999.30 | +13.0% | |
| Feb 24, 2021 | Equels Thomas K. | CEO &President | Buy | 11,062 | $2.26 | $25,000.12 | +5.6% | |
| Dec 17, 2020 | Equels Thomas K. | CEO | Buy | 14,535 | $1.72 | $25,000.20 | +7.9% | |
| Sep 3, 2020 | Equels Thomas K. | CEO &President | Buy | 12,316 | $2.03 | $25,001.48 | +7.2% | |
| Aug 21, 2020 | Equels Thomas K. | CEO | Buy | 10,730 | $2.33 | $25,000.90 | +6.7% | |
| Jun 27, 2019 | Equels Thomas K. | Executive Vice Chairman/ Ceo/ President | Buy | 2,632 | $4.37 | $11,501.84 | +4.4% | |
| Jun 21, 2019 | Strayer David R | Chief Science/ Medical Officer | Buy | 2,481 | $4.03 | $9,998.43 | +84.4% | |
| Jun 21, 2019 | Rodino III Peter W. | Director Govt Relations/ Sectry | Buy | 8,695 | $4.03 | $35,040.85 | +223.2% | |
| Jun 21, 2019 | Equels Thomas K. | Executive Vice Chairman/ Ceo/ President | Buy | 29,404 | $4.03 | $118,498.12 | +2.2% | |
| Jun 21, 2019 | Appelrouth Stewart | Director | Buy | 9,677 | $4.03 | $38,998.31 | +56.8% |